Deutsche Bank’s Repros Therapeutics Inc. RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,446
Closed -$5K 5355
2016
Q3
$5K Sell
2,446
-2
-0.1% -$4 ﹤0.01% 4769
2016
Q2
$3K Sell
2,448
-43,731
-95% -$83.9K ﹤0.01% 5077
2016
Q1
$44K Sell
46,179
-17,460
-27% -$17K ﹤0.01% 4369
2015
Q4
$77K Buy
63,639
+29,688
+87% +$95.3K ﹤0.01% 4183
2015
Q3
$251K Sell
33,951
-99,877
-75% -$764K ﹤0.01% 3697
2015
Q2
$956K Buy
133,828
+56,993
+74% +$444K ﹤0.01% 2992
2015
Q1
$659K Buy
76,835
+67,109
+690% +$600K ﹤0.01% 3150
2014
Q4
$96K Buy
9,726
+622
+7% +$5.3K ﹤0.01% 4748
2014
Q3
$89K Sell
9,104
-5,323
-37% -$78.8K ﹤0.01% 4577
2014
Q2
$249K Sell
14,427
-28,809
-67% -$470K ﹤0.01% 3989
2014
Q1
$766K Sell
43,236
-21,187
-33% -$410K ﹤0.01% 3051
2013
Q4
$1.18M Buy
64,423
+25,969
+68% +$490K ﹤0.01% 2564
2013
Q3
$1.03M Sell
38,454
-55,945
-59% -$1.2M ﹤0.01% 2955
2013
Q2
$1.74M Buy
+94,399
New +$1.67M ﹤0.01% 2318

Other funds holding RPRX

Deutsche Bank's RPRX Position: Q4 2016 in Review

Deutsche Bank sold out of Repros Therapeutics Inc. (RPRX) in Q4 2016, closing a stake of 2,446 shares — an estimated $5K sold.

Deutsche Bank first reported a position in RPRX in Q2 2013 and held it in 14 quarters. The position peaked at $1.74M in Q2 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

  • Deutsche Bank reported no remaining Repros Therapeutics Inc. position as of Q4 2016 after selling out during the quarter.
  • Deutsche Bank sold 2,446 Repros Therapeutics Inc. shares in Q4 2016, an estimated $5K.
  • Deutsche Bank first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 14 quarters.
  • Deutsche Bank's Repros Therapeutics Inc. position peaked at $1.74M in Q2 2013.
  • 43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.